Table 1.

bFGF levels in five subgroups of “benign” cases and six subgroups of “high-risk” cases (mean ± SE, in pg/mL)

(A) Benign group
BenignNormalHyperplasiaCystFibroadenomaPapilloma
bFGF129.87 ± 10.97130.85 ± 43.33187.56 ± 44.77238.71 ± 76.32424.9 ± 216.85
n9261857
Pnonsignificantnonsignificantnonsignificantnonsignificant0.01
(B) High-risk group
Risk
Normal
Hyperplasia
Cyst
Phylloides
Precancer
Contralateral cancer
bFGF224.44 ± 32.13244.46 ± 83.0333.221276.2416.42 ± 166.561,524.86 ± 1,214.76
n33411914
Pnonsignificantnonsignificantnonsignificantnonsignificantnonsignificantnonsignificant